IN8BIO, INC. (INAB) · INSIDERData sourcesSEC Form 414m ago
House PTR13m ago
SEC 13F13m ago
Robinhood Chain13m ago
Public companyIN8BIO, INC.
INABCIK 0001740279
Price$0.82
1 year-51.8%
Disclosed transactions11
Buys / sells0 / 0
Max Insider Score21
Connections with evidence7
INAB · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 9 | | INABIN8BIO, INC. Grant or award | A | — 22.0K sh | May 9, 2026 | May 12, 2026 |
| 9 | GRGraff Jeremy R.Director | INABIN8BIO, INC. Grant or award | A | — 22.0K sh | May 9, 2026 | May 12, 2026 traded May 9, 2026 | +3d | SEC Form 4 | |
| 9 | MPMcCall PatrickCHIEF FINANCIAL OFFICER | INABIN8BIO, INC. Grant or award | A | — 56.3K sh | May 9, 2026 | May 12, 2026 traded May 9, 2026 | +3d | SEC Form 4 | |
| 9 | RKRochlin KatePresident and COO | INABIN8BIO, INC. Grant or award | A | — 60.0K sh | May 9, 2026 | May 12, 2026 traded May 9, 2026 | +3d | SEC Form 4 | |
| 9 | HWHo William Tai-WeiDirector, CEO, 10% Owner | INABIN8BIO, INC. Grant or award | A | — 206.0K sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 9 | LLLamb LawrenceEVP and CSO | INABIN8BIO, INC. Grant or award | A | — 72.0K sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 9 | RKRochlin KatePresident and COO | INABIN8BIO, INC. Grant or award | A | — 80.0K sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 9 | MPMcCall PatrickCHIEF FINANCIAL OFFICER | INABIN8BIO, INC. Grant or award | A | — 75.0K sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 21 | MPMcCall PatrickCHIEF FINANCIAL OFFICER | INABIN8BIO, INC. Grant or award | A | $10K 7,247 sh | Dec 22, 2025 | Dec 23, 2025 traded Dec 22, 2025 | +1d | SEC Form 4 | |
| 21 | RKRochlin KateChief Operating Officer | INABIN8BIO, INC. Grant or award | A | $10K 7,247 sh | Dec 22, 2025 | Dec 23, 2025 traded Dec 22, 2025 | +1d | SEC Form 4 | |
| 20 | HWHo William Tai-WeiDirector, PRESIDENT AND CEO, 10% Owner | INABIN8BIO, INC. Grant or award | A | $50K 36.2K sh | Dec 22, 2025 | Dec 23, 2025 traded Dec 22, 2025 | +1d | SEC Form 4 | |
CHIEF FINANCIAL OFFICER · Dec 23, 2025